🇺🇸 FDA
Pipeline program

6R-BH4

NA_00014296

Phase 2 small_molecule terminated

Quick answer

6R-BH4 for Isolated Systolic Hypertension is a Phase 2 program (small_molecule) at BIOMARIN PHARMACEUTICAL INC with 1 ClinicalTrials.gov record(s).

Program details

Company
BIOMARIN PHARMACEUTICAL INC
Indication
Isolated Systolic Hypertension
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials